United States Pharmaceuticals

Bausch Health Companies Inc (BHC)

Track

Over the past 90 days, Bausch Health Companies Inc. has seen five insider transactions, all of which were sales totaling approximately $668,388. These transactions occurred following the company's July 2026 earnings report, which showed a 24.75% earnings beat. The stock has experienced an 11.7% price increase over the last three months.
Ticker: BHC Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bausch Health Companies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Dautbegovic, Mirza Senior Officer of Issuer Officer
Transaction date
Sale
Price
270.44
Quantity 77,463 -3.3%
Value US$4,412,658
Dautbegovic, Mirza Senior Officer of Issuer Officer
Transaction date
Sale
Price
350.90
Quantity 20,362 +4.7%
Value US$4,316,866
3.2
Lee, Frank Don Director of Issuer Non-Executive Director
Transaction date
Sale
Price
363.16
Quantity 45,654 -48.3%
Value US$1,491,238
3.7
Lee Frank D. Non-Executive Director
Transaction date
Planned sale
Price
5.43
Quantity 24,456 -33.1%
Value US$132,796
3.7
Lee Frank D. Director Non-Executive Director
Transaction date
Proposed sale
Price
5.43
Quantity 24,456
Value US$132,796
Dautbegovic, Mirza Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.00
Quantity 20,000 -6.6%
Value US$120,000
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
5.77
Quantity 4,420 -1.8%
Value US$25,503
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
5.77
Quantity 4,420 -0.7%
Value US$25,503
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
5.77
Quantity 4,420
Value US$25,503
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
5.78
Quantity 6,856 -2.7%
Value US$39,628
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
5.78
Quantity 6,856 -0.9%
Value US$39,628
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
5.78
Quantity 6,856
Value US$39,628
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
5.95
Quantity 8,388 -3.7%
Value US$49,909
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
5.95
Quantity 8,388 -1.0%
Value US$49,909
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
5.95
Quantity 8,388
Value US$49,909
2.1
Ross Sr., Thomas Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Sale
Price
7.00
Quantity 11,500
Value US$80,500
3.7
Munsch, Frederick John Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.00
Quantity 21,568
Value US$150,976
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
6.25
Quantity 2,500,000
Value US$15,625,000
3.7
PAULSON & CO. INC. Large shareholder
Transaction date
Purchase
Price
6.25
Quantity 2,500,000 +3.5%
Value US$15,625,000
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
7.31
Quantity 13,370
Value US$97,735
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.31
Quantity 13,370 -6.4%
Value US$97,735
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
7.31
Quantity 13,370 -2.6%
Value US$97,735
3.2
Lee, Frank Don Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.66
Quantity 15,912 -45.0%
Value US$121,886
3.7
Lee Frank D. Non-Executive Director
Transaction date
Sale
Price
7.66
Quantity 15,912 -17.7%
Value US$121,886
3.7
Lee Frank D. Director Non-Executive Director
Transaction date
Proposed sale
Price
7.66
Quantity 15,912
Value US$121,888
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
9.00
Quantity 34,721,118 +1070.6%
Value US$312,490,062
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
9.00
Quantity 34,721,118 +96.4%
Value US$312,490,062
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
7.06
Quantity 86,409 +2.7%
Value US$610,048
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
7.06
Quantity 86,409 +0.2%
Value US$610,048
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
6.88
Quantity 1,156,640 +57.8%
Value US$7,957,683
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
6.88
Quantity 1,156,640 +3.3%
Value US$7,957,683
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
6.35
Quantity 2,000,000
Value US$12,700,000
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
6.35
Quantity 2,000,000 +6.1%
Value US$12,700,000
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.94
Quantity 1,782,030 +13.1%
Value US$10,585,258
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.94
Quantity 1,782,029 +28.6%
Value US$10,585,252
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.94
Quantity 3,564,059 +12.2%
Value US$21,170,510
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.47
Quantity 502,688 +3.8%
Value US$2,749,703
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.47
Quantity 502,688 +8.8%
Value US$2,749,703
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.47
Quantity 1,005,376 +3.6%
Value US$5,499,407
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.24
Quantity 514,549 +4.1%
Value US$2,696,237
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.24
Quantity 514,549 +9.9%
Value US$2,696,237
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.24
Quantity 1,029,098 +3.8%
Value US$5,392,474
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.05
Quantity 754,134
Value US$3,808,377
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.05
Quantity 754,134 +2.9%
Value US$3,808,377
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
8.35
Quantity 440 -0.1%
Value US$3,674
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
8.35
Quantity 440
Value US$3,674
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
6.21
Quantity 13,370 -3.0%
Value US$83,028
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.21
Quantity 13,370 -10.0%
Value US$83,028
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
6.21
Quantity 13,370
Value US$83,028
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
9.80
Quantity 6,313
Value US$61,867
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 133 -0.0%
Value US$1,303
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 1,561 -0.3%
Value US$15,298
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 199 -0.0%
Value US$1,950
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 4,420 -0.9%
Value US$43,316
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
7.38
Quantity 220
Value US$1,624
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
7.38
Quantity 220 -0.1%
Value US$1,624
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.61
Quantity 43 -0.1%
Value US$327
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
7.61
Quantity 43
Value US$327
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
7.61
Quantity 43 -0.0%
Value US$327
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 6,685
Value US$55,352
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
8.28
Quantity 6,685 -1.7%
Value US$55,352
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
9.17
Quantity 495
Value US$4,539
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
9.32
Quantity 292 -1.3%
Value US$2,721
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.32
Quantity 292 -0.1%
Value US$2,721
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
22.19
Quantity 1,595 -1.7%
Value US$35,393
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
22.20
Quantity 4,846 -5.0%
Value US$107,581
Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l Officer
Transaction date
Planned sale
Price
21.76
Quantity 3,889 -4.0%
Value US$84,625
Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l Officer
Transaction date
Planned sale
Price
23.37
Quantity 11,077 -9.9%
Value US$258,869
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
23.37
Quantity 1,595 -2.4%
Value US$37,275
Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l Officer
Transaction date
Planned sale
Price
23.82
Quantity 6,338 -5.3%
Value US$150,971
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
25.02
Quantity 3,251 -5.1%
Value US$81,340
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
26.63
Quantity 3,251 -4.9%
Value US$86,574
1.6
Miller Steven D Non-Executive Director
Transaction date
Purchase
Price
24.17
Quantity 10,000 +inf%
Value US$241,699
1.6
Miller Steven D Non-Executive Director
Transaction date
Purchase
Price
24.24
Quantity 50,000 +463.8%
Value US$1,211,825
1.0
Eldessouky Sam EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
31.68
Quantity 17,000 -12.7%
Value US$538,586
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-04 2026-08-03 S Sale
Dautbegovic, Mirza

Senior Officer of Issuer

Officer
77,463 -3.3%
270.44
US$4,412,658 		77,463 -3.3% 270.44 US$4,412,658
2026-08-04 2026-07-31 S Sale
Dautbegovic, Mirza

Senior Officer of Issuer

Officer
20,362 +4.7%
350.90
US$4,316,866 		20,362 +4.7% 350.90 US$4,316,866
2026-05-20 2026-05-19 S Sale
3.2
Lee, Frank Don

Director of Issuer

Non-Executive Director
45,654 -48.3%
363.16
US$1,491,238 		45,654 -48.3% 363.16 US$1,491,238
2026-05-20 2026-05-19 PlS Planned sale
3.7
Lee Frank D.
Non-Executive Director
24,456 -33.1%
5.43
US$132,796 		24,456 -33.1% 5.43 US$132,796
2026-05-19 2026-05-19 PrS Proposed sale
3.7
Lee Frank D.

Director

Non-Executive Director
24,456
5.43
US$132,796 		24,456 5.43 US$132,796
2026-05-01 2026-04-30 S Sale
Dautbegovic, Mirza

Senior Officer of Issuer

Officer
20,000 -6.6%
6.00
US$120,000 		20,000 -6.6% 6.00 US$120,000
2026-03-04 2026-03-03 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
4,420 -1.8%
5.77
US$25,503 		4,420 -1.8% 5.77 US$25,503
2026-03-03 2026-03-03 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
4,420 -0.7%
5.77
US$25,503 		4,420 -0.7% 5.77 US$25,503
2026-03-03 2026-03-03 PrS Proposed sale
Carson Seana

Officer

Officer
4,420
5.77
US$25,503 		4,420 5.77 US$25,503
2026-03-04 2026-03-02 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
6,856 -2.7%
5.78
US$39,628 		6,856 -2.7% 5.78 US$39,628
2026-03-03 2026-03-02 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
6,856 -0.9%
5.78
US$39,628 		6,856 -0.9% 5.78 US$39,628
2026-03-02 2026-03-02 PrS Proposed sale
Carson Seana

Officer

Officer
6,856
5.78
US$39,628 		6,856 5.78 US$39,628
2026-03-02 2026-02-27 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
8,388 -3.7%
5.95
US$49,909 		8,388 -3.7% 5.95 US$49,909
2026-02-27 2026-02-27 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
8,388 -1.0%
5.95
US$49,909 		8,388 -1.0% 5.95 US$49,909
2026-02-27 2026-02-27 PrS Proposed sale
Carson Seana

Officer

Officer
8,388
5.95
US$49,909 		8,388 5.95 US$49,909
2025-12-08 2025-12-03 S Sale
2.1
Ross Sr., Thomas

Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
11,500
7.00
US$80,500 		11,500 7.00 US$80,500
2025-12-08 2025-12-03 S Sale
3.7
Munsch, Frederick John

Senior Officer of Issuer

Officer
21,568
7.00
US$150,976 		21,568 7.00 US$150,976
2025-11-28 2025-11-25 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
2,500,000
6.25
US$15,625,000 		2,500,000 6.25 US$15,625,000
2025-11-28 2025-11-25 B Purchase
3.7
PAULSON & CO. INC.
Large shareholder
2,500,000 +3.5%
6.25
US$15,625,000 		2,500,000 +3.5% 6.25 US$15,625,000
2025-09-08 2025-09-08 PrS Proposed sale
Carson Seana

Officer

Officer
13,370
7.31
US$97,735 		13,370 7.31 US$97,735
2025-09-08 2025-09-08 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
13,370 -6.4%
7.31
US$97,735 		13,370 -6.4% 7.31 US$97,735
2025-09-08 2025-09-08 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
13,370 -2.6%
7.31
US$97,735 		13,370 -2.6% 7.31 US$97,735
2025-08-27 2025-08-21 S Sale
3.2
Lee, Frank Don

Director of Issuer

Non-Executive Director
15,912 -45.0%
7.66
US$121,886 		15,912 -45.0% 7.66 US$121,886
2025-08-22 2025-08-21 S Sale
3.7
Lee Frank D.
Non-Executive Director
15,912 -17.7%
7.66
US$121,886 		15,912 -17.7% 7.66 US$121,886
2025-08-21 2025-08-21 PrS Proposed sale
3.7
Lee Frank D.

Director

Non-Executive Director
15,912
7.66
US$121,888 		15,912 7.66 US$121,888
2025-08-15 2025-08-14 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
34,721,118 +1070.6%
9.00
US$312,490,062 		34,721,118 +1070.6% 9.00 US$312,490,062
2025-08-14 2025-08-14 B Purchase
3.0
Paulson John
Non-Executive Director
34,721,118 +96.4%
9.00
US$312,490,062 		34,721,118 +96.4% 9.00 US$312,490,062
2025-08-13 2025-08-13 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
86,409 +2.7%
7.06
US$610,048 		86,409 +2.7% 7.06 US$610,048
2025-08-13 2025-08-13 B Purchase
3.0
Paulson John
Non-Executive Director
86,409 +0.2%
7.06
US$610,048 		86,409 +0.2% 7.06 US$610,048
2025-08-13 2025-08-12 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,156,640 +57.8%
6.88
US$7,957,683 		1,156,640 +57.8% 6.88 US$7,957,683
2025-08-13 2025-08-12 B Purchase
3.0
Paulson John
Non-Executive Director
1,156,640 +3.3%
6.88
US$7,957,683 		1,156,640 +3.3% 6.88 US$7,957,683
2025-08-13 2025-08-11 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
2,000,000
6.35
US$12,700,000 		2,000,000 6.35 US$12,700,000
2025-08-13 2025-08-11 B Purchase
3.0
Paulson John
Non-Executive Director
2,000,000 +6.1%
6.35
US$12,700,000 		2,000,000 +6.1% 6.35 US$12,700,000
2025-06-17 2025-06-13 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,782,030 +13.1%
5.94
US$10,585,258 		1,782,030 +13.1% 5.94 US$10,585,258
2025-06-17 2025-06-13 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,782,029 +28.6%
5.94
US$10,585,252 		1,782,029 +28.6% 5.94 US$10,585,252
2025-06-17 2025-06-13 B Purchase
3.0
Paulson John
Non-Executive Director
3,564,059 +12.2%
5.94
US$21,170,510 		3,564,059 +12.2% 5.94 US$21,170,510
2025-06-16 2025-06-12 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
502,688 +3.8%
5.47
US$2,749,703 		502,688 +3.8% 5.47 US$2,749,703
2025-06-16 2025-06-12 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
502,688 +8.8%
5.47
US$2,749,703 		502,688 +8.8% 5.47 US$2,749,703
2025-06-12 2025-06-12 B Purchase
3.0
Paulson John
Non-Executive Director
1,005,376 +3.6%
5.47
US$5,499,407 		1,005,376 +3.6% 5.47 US$5,499,407
2025-06-16 2025-06-11 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
514,549 +4.1%
5.24
US$2,696,237 		514,549 +4.1% 5.24 US$2,696,237
2025-06-16 2025-06-11 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
514,549 +9.9%
5.24
US$2,696,237 		514,549 +9.9% 5.24 US$2,696,237
2025-06-12 2025-06-11 B Purchase
3.0
Paulson John
Non-Executive Director
1,029,098 +3.8%
5.24
US$5,392,474 		1,029,098 +3.8% 5.24 US$5,392,474
2025-06-14 2025-06-10 B Purchase
3.4
Paulson, John

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
754,134
5.05
US$3,808,377 		754,134 5.05 US$3,808,377
2025-06-12 2025-06-10 B Purchase
3.0
Paulson John
Non-Executive Director
754,134 +2.9%
5.05
US$3,808,377 		754,134 +2.9% 5.05 US$3,808,377
2024-12-03 2024-12-02 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
440 -0.1%
8.35
US$3,674 		440 -0.1% 8.35 US$3,674
2024-12-02 2024-12-02 PrS Proposed sale
Carson Seana

Officer

Officer
440
8.35
US$3,674 		440 8.35 US$3,674
2024-09-09 2024-09-06 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
13,370 -3.0%
6.21
US$83,028 		13,370 -3.0% 6.21 US$83,028
2024-09-09 2024-09-06 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
13,370 -10.0%
6.21
US$83,028 		13,370 -10.0% 6.21 US$83,028
2024-09-06 2024-09-06 PrS Proposed sale
Carson Seana

Officer

Officer
13,370
6.21
US$83,028 		13,370 6.21 US$83,028
2024-03-04 2024-03-04 PrS Proposed sale
Carson Seana

Officer

Officer
6,313
9.80
US$61,867 		6,313 9.80 US$61,867
2024-03-04 2024-03-04 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
133 -0.0%
9.80
US$1,303 		133 -0.0% 9.80 US$1,303
2024-03-04 2024-03-04 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
1,561 -0.3%
9.80
US$15,298 		1,561 -0.3% 9.80 US$15,298
2024-03-04 2024-03-04 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
199 -0.0%
9.80
US$1,950 		199 -0.0% 9.80 US$1,950
2024-03-04 2024-03-04 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
4,420 -0.9%
9.80
US$43,316 		4,420 -0.9% 9.80 US$43,316
2023-12-05 2023-12-05 PrS Proposed sale
Carson Seana

Officer

Officer
220
7.38
US$1,624 		220 7.38 US$1,624
2023-12-05 2023-12-05 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
220 -0.1%
7.38
US$1,624 		220 -0.1% 7.38 US$1,624
2023-11-07 2023-11-06 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
43 -0.1%
7.61
US$327 		43 -0.1% 7.61 US$327
2023-11-06 2023-11-06 PrS Proposed sale
Carson Seana

Officer

Officer
43
7.61
US$327 		43 7.61 US$327
2023-11-06 2023-11-06 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
43 -0.0%
7.61
US$327 		43 -0.0% 7.61 US$327
2023-09-06 2023-09-06 PrS Proposed sale
Carson Seana

Officer

Officer
6,685
8.28
US$55,352 		6,685 8.28 US$55,352
2023-09-06 2023-09-06 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
6,685 -1.7%
8.28
US$55,352 		6,685 -1.7% 8.28 US$55,352
2023-03-06 2023-03-06 PrS Proposed sale
Carson Seana

Officer

Officer
495
9.17
US$4,539 		495 9.17 US$4,539
2023-03-01 2023-02-28 S Sale
2.9
Carson, Seana Lynne

Senior Officer of Issuer

Officer
292 -1.3%
9.32
US$2,721 		292 -1.3% 9.32 US$2,721
2023-03-01 2023-02-28 PlS Planned sale
Carson Seana

EVP, General Counsel

Officer
292 -0.1%
9.32
US$2,721 		292 -0.1% 9.32 US$2,721
2022-04-15 2022-04-14 PlS Planned sale
Spurr Robert

U.S. President-Pharma Business

Officer
1,595 -1.7%
22.19
US$35,393 		1,595 -1.7% 22.19 US$35,393
2022-03-16 2022-03-15 PlS Planned sale
Spurr Robert

U.S. President-Pharma Business

Officer
4,846 -5.0%
22.20
US$107,581 		4,846 -5.0% 22.20 US$107,581
2022-03-10 2022-03-08 PlS Planned sale
Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

Officer
3,889 -4.0%
21.76
US$84,625 		3,889 -4.0% 21.76 US$84,625
2022-03-04 2022-03-02 PlS Planned sale
Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

Officer
11,077 -9.9%
23.37
US$258,869 		11,077 -9.9% 23.37 US$258,869
2022-03-04 2022-03-02 PlS Planned sale
Spurr Robert

U.S. President-Pharma Business

Officer
1,595 -2.4%
23.37
US$37,275 		1,595 -2.4% 23.37 US$37,275
2022-03-02 2022-03-01 PlS Planned sale
Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

Officer
6,338 -5.3%
23.82
US$150,971 		6,338 -5.3% 23.82 US$150,971
2022-02-17 2022-02-15 PlS Planned sale
Spurr Robert

U.S. President-Pharma Business

Officer
3,251 -5.1%
25.02
US$81,340 		3,251 -5.1% 25.02 US$81,340
2022-01-20 2022-01-18 PlS Planned sale
Spurr Robert

U.S. President-Pharma Business

Officer
3,251 -4.9%
26.63
US$86,574 		3,251 -4.9% 26.63 US$86,574
2021-12-02 2021-11-30 B Purchase
1.6
Miller Steven D
Non-Executive Director
10,000 +inf%
24.17
US$241,699 		10,000 +inf% 24.17 US$241,699
2021-12-02 2021-11-30 B Purchase
1.6
Miller Steven D
Non-Executive Director
50,000 +463.8%
24.24
US$1,211,825 		50,000 +463.8% 24.24 US$1,211,825
2021-06-15 2021-06-11 S Sale
1.0
Eldessouky Sam

EVP & Chief Financial Officer

Officer
17,000 -12.7%
31.68
US$538,586 		17,000 -12.7% 31.68 US$538,586
Explore more

More insider trading research around Bausch Health Companies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America
Insider trades in S&P TSX Composite Index (Canada)